Atiyah Wang is an associate in the intellectual property (“IP”) transactions group. She advises clients in a wide range of transactions where technology, data or other IP assets are key elements, including mergers and acquisitions, financings, license agreements, complex collaborations, product funding and co-development agreements, royalty monetization agreements and general commercial agreements. Her practice particularly focuses on transactions relating to digital health and artificial intelligence. She has digital health product counselling experience through multiple secondments as a senior corporate counsel to the Digital Transactions Group at Sanofi. Leveraging her doctorate in electrical engineering and her background in patent prosecution and litigation, Atiyah also provides strategic counselling to clients on a variety of patent matters, including development and management of patent portfolios, pre-litigation review and freedom-to-operate analyses.

Prior to joining the IP transactions group, Atiyah worked on district court and ITC patent litigation proceedings and post-grant proceedings in a wide range of technical areas, including wireless communications, computer security, semiconductors and media services. She also prosecuted an extensive global patent portfolio, primarily relating to media services and semiconductor technologies.

During her doctoral studies, Atiyah optimized optical networking technologies to enable greater Internet bandwidth at lower latency and higher energy-efficiency. Her graduate work was a foundational element for the Center for Integrated Access Networks (“CIAN”), a multi-university research consortium set up by the National Science Foundation. Through CIAN, Atiyah collaborated with multiple leading optical networking research groups in U.S. and Europe and has contributed to several peer reviewed journal articles and conference proceedings. Atiyah also co-founded a start-up company, PICXIE, to evaluate commercialization opportunities for a patented optical monitoring technology developed through CIAN.


Digital Health Transactions

  • Represented Recursion Pharmaceuticals in its collaboration with Enamine, a Kyiv, Ukraine based provider of novel molecules, to generate enriched screening libraries by utilizing Recursion's machine learning enabled platform for predicting protein-ligand interactions, MatchMaker, to Enamine's library of approximately thirty-six billion compounds.
  • Represented, a software company offering meditation and sleep solutions in its subscription-based app, in a strategic partnership agreement with a pharmacy, care, and benefits solution provider.
  • Represented Atomwise, an AI small molecule drug discovery company, in negotiating a $1+ billion multi-target collaboration with Sanofi to identify potential active compounds associated with certain targets of interest to accelerate Sanofi's drug development pipeline.
  • Represented Sixth Street, a leading global investment firm, in connection with its Series C equity investment in ConcertAI, LLC, a provider of software-as-a-service and data solutions for clinical research, leveraging real-world evidence, artificial intelligence technology, and scientific expertise to accelerate insights and outcomes for patients.

Other Data and Technology Transactions

  • Advised TPG in connection with the sale of McAfee’s enterprise business to Symphony Technology Group in an all-cash carve-out transaction for $4 billion.
  • Advised TPG Capital and Francisco Partners in connection with their joint acquisition of Boomi, a provider of cloud-based integration platform as a service (iPaaS), from Dell Technologies for $4 billion.
  • Advised TPG in connection with its simultaneous carve-out acquisition of AT&T’s television business, including DirecTV and AT&T TV, and purchase of a 30% stake in the newly carved-out business for $1.8 billion.
  • Advised TPG Capital and its portfolio company Ellucian, specializing in information technology software and services designed for higher education institutions, in connection with the sale of Ellucian to private equity companies.
  • Advised a private equity firm in connection with its early-stage investment in a company offering an AI-powered computer vision platform for improving business outcomes in supply chain and retail industries.
  • Advised a private equity firm in connection with its low triple digit million dollar equity investment at low single digit billion dollar valuation in a company providing AI driven insights and automation for IT data.

Patent Litigation

  • Emerson Electric v. SIPCO et al. (N.D. Ga., ITC, PTAB): Served as technical advisor to Emerson Electric in a 10-patent lawsuit, multiple inter partes review proceedings, re-examination proceedings and ITC proceedings relating to mesh network technology, securing a favorable decision in each case and appeal that reached a final decision.
  • Blue Spike, LLC v. Roku, Inc. (D. Del.): Served as technical advisor to Roku in a seven-patent suit relating to secure transactions, which resulted in a favorable settlement on behalf of Roku.

Areas of Practice